First Command Bank Gilead Sciences, Inc. Transaction History

First Command Bank

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2020 Jan 19, 2021	SELL	$56.65 - $64.55 $5,665 - $6,455	-100 Closed	0 $0
Q4 2019 Jan 14, 2020	SELL	$61.62 - $67.78 $431 - $474	-7 Reduced 6.54%	100 $6,000
Q2 2019 Jul 11, 2019	SELL	$61.87 - $69.38 $4,640 - $5,203	-75 Reduced 41.21%	107 $7,000
Q4 2018 Jan 18, 2019	BUY	$60.54 - $79.0 $4,540 - $5,925	75 Added 70.09%	182 $11,000
Q2 2018 Jul 20, 2018	BUY	$64.88 - $75.68 $6,942 - $8,097	107 New	107 $8,000

1,927

994M

10.5M

9.75M

Ticker GILD
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,253,369,984
Market Cap $116B
Description
Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...

Get notified when there are updates to the investment portfolio of First Command Bank, based on Form 13F filings with the SEC.

Stay updated on First Command Bank with notifications on news.